Nom du produit:2,4-dichloropyrimidine-5-carbonyl chloride

IUPAC Name:2,4-dichloropyrimidine-5-carbonyl chloride

CAS:2972-52-3
Formule moléculaire:C5HCl3N2O
Pureté:95%+
Numéro de catalogue:CM100730
Poids moléculaire:211.43

Unité d'emballage Stock disponible Prix($) Quantité
CM100730-5g in stock ŭşœ
CM100730-10g in stock Əœœ
CM100730-25g in stock şƩȋ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2972-52-3
Formule moléculaire:C5HCl3N2O
Point de fusion:-
Code SMILES:O=C(Cl)C1=CN=C(Cl)N=C1Cl
Densité:1.675g/cm3
Numéro de catalogue:CM100730
Poids moléculaire:211.43
Point d'ébullition:304.3°C at 760 mmHg
N° Mdl:MFCD09742432
Stockage:Store at 2-8°C.

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Cerdulatinib
Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).

Related Products